References
- Chen J, McMillan NA. Molecular basis of pathogenesis, prognosis and therapy in chronic lymphocytic leukaemia. Cancer Biol Ther 2008;7:174–179.
- Gricks CS, Gribben JG. Cytotoxic T cell responses against immunoglobulin in malignant and normal B cells: implications for tumor immunity and autoimmunity. Curr Pharm Des 2003;9:1889–1903.
- Spaner DE, Shi Y, White D, . Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells. Leukemia 2006;20:286–295.
- Grandjenette C, Kennel A, Faure GC, . Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cells. Haematologica 2007;92:1279–1281.
- Rozková D, Novotná L, Pytlík R, . Toll-like receptors on CLL cells: expression and functional consequences of their stimulation. Int J Cancer 2010;126:1132–1143.
- Lenert PS. Classification, mechanisms of action, and therapeutic applications of inhibitory oligonucleotides for Toll-like receptors (TLR) 7 and 9. Mediators Inflamm 2010;2010:986596.
- Hammadi A, Billard C, Faussat AM, . Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-κB activation. Nitric Oxide 2008;19:138–145.
- Schön MP, Schön M. Imiquimod: mode of action. Br J Dermatol 2007;157(Suppl. 2):8–13.
- Collins RJ, Verschuer LA, Harmon BV, . Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. Neoplasma 2004;51:181–187.
- Pepper C, Thomas A, Hoy T, . The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro. Blood 2003;101: 2454–2460.
- Bottrel RL, Yang YL, Levy DE, . The immune response modifier imiquimod requires STAT-1 for induction of interferon, interferon-stimulated genes, and interleukin-6. Antimicrob Agents Chemother 1999;43:856–861.
- Megyeri K, Au WC, Rosztoczy I, . Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways. Mol Cell Biol 1995;15:2207–2218.
- Büssing A. Release of interleukin-6 in cultured B-chronic lymphocytic leukaemia cells is associated with both activation and cell death via apoptosis. Anticancer Res 1999;19:3953–3959.
- Francia di Celle P, Mariani S, Riera L, . Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood 1996;87: 4382–4389.
- Spaner DE, Shi Y, White D, . A phase I/II trial of TLR-7 agonist immunotherapy in chronic lymphocytic leukemia. Leukemia 2010;24:222–226.